European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Portugal — market report, April 2025

Oncology drug tenders in Portugal in April 2025: 1,156 tenders published (-19% month on month, +135% year on year), estimated at €37,861,645 in total, and 971 contracts awarded (-32% month on month, +123% year on year), worth €3,120,536 (awarded value). Buyers with the most tenders: Unidade Local de Saúde do Alto Alentejo, E. P. E. (164), Unidade Local de Saúde de Santa Maria, E. P. E. (101) and Unidade Local de Saúde de São José, E. P. E. (81); most contracts won: Generis – Farmaceutica, S.A. (113), Teva Pharma - Produtos Farmaceuticos,lda (62) and Fresenius Kabi Pharma Portugal (53). On average 21.6 bids per contract; 7% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
1,156
Contracts awarded
971
Contract value awarded
€3,120,536
Bids per contract
21.6
Tenders published per month
05001K1.5KApr 24: 492Apr 24: 492Apr 24May 24: 92May 24: 92May 24Jun 24: 136Jun 24: 136Jun 24Jul 24: 143Jul 24: 143Jul 24Aug 24: 62Aug 24: 62Aug 24Sep 24: 294Sep 24: 294Sep 24Oct 24: 241Oct 24: 241Oct 24Nov 24: 230Nov 24: 230Nov 24Dec 24: 967Dec 24: 967Dec 24Jan 25: 1,160Jan 25: 1,160Jan 25Feb 25: 931Feb 25: 931Feb 25Mar 25: 1,431Mar 25: 1,431Mar 25Apr 25: 1,156Apr 25: 1,1561,156Apr 25
Contracts awarded per month
05001K1.5KApr 24: 435Apr 24: 435Apr 24May 24: 65May 24: 65May 24Jun 24: 86Jun 24: 86Jun 24Jul 24: 95Jul 24: 95Jul 24Aug 24: 78Aug 24: 78Aug 24Sep 24: 253Sep 24: 253Sep 24Oct 24: 199Oct 24: 199Oct 24Nov 24: 386Nov 24: 386Nov 24Dec 24: 1,212Dec 24: 1,212Dec 24Jan 25: 1,017Jan 25: 1,017Jan 25Feb 25: 1,143Feb 25: 1,143Feb 25Mar 25: 1,418Mar 25: 1,418Mar 25Apr 25: 971Apr 25: 971971Apr 25

The highlighted bar is April 2025. Hover a bar for its figure; the table below has every value.

FigureApril 2025March 2025ChangeApril 2024Change
Tenders published1,1561,431-19%492+135%
Estimated value€37,861,645€906,609+4,076%€56,782+66,579%
Buyers3132-3%30+3%
Contracts awarded9711,418-32%435+123%
Contract value (awarded)€3,120,536€57,801,485-95%€595,669+424%
Winners5674-24%34+65%
Bids per contract21.619.7—13.3—
Single-bid contracts7%11%—6%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Grande Lisboa 26

Procedures

  • not stated 1,130
  • Restricted procedure 26

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Portugal in April 2025?
1,156 (by 31 buyers); for comparison, March 2025: 1,431, April 2024: 492.
Who won the most oncology drug tenders in Portugal in April 2025?
By number of contracts: Generis – Farmaceutica, S.A. (113), Teva Pharma - Produtos Farmaceuticos,lda (62), Fresenius Kabi Pharma Portugal (53), Labesfal-Lab. Almiro, Sa. (47) and MYLAN, Lda. (42); 56 companies won contracts in all.
Which buyers published the most oncology drug tenders in April 2025?
Unidade Local de Saúde do Alto Alentejo, E. P. E. (164), Unidade Local de Saúde de Santa Maria, E. P. E. (101), Unidade Local de Saúde de São José, E. P. E. (81), Unidade Local de Saúde da Cova da Beira, E. P. E. (62) and Unidade Local de Saúde Póvoa de Varzim/Vila do Conde, E. P. E. (51).
How competitive were oncology drug tenders in Portugal in April 2025?
On average 21.6 bids per contract (201 contracts with a known number of bids); 7% of contracts had a single bid.
What were the contracts worth in April 2025?
€3,120,536 (awarded value, 971 contracts); median about €140,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.